A 68-year-old man with COPD presents with fever, cough productive of purulent sputum, and dyspnea for 3 days. Chest X-ray shows a left lower lobe consolidation. Vital signs: HR 110/min, RR 28/min, BP 130/85 mmHg, SpO₂ 88% on room air. Which investigation is most appropriate to guide initial antibiotic therapy in community-acquired pneumonia?

## Investigation of Choice in CAP **Key Point:** Blood culture and sputum Gram stain with culture are the gold-standard investigations for microbiological diagnosis and guiding targeted antibiotic therapy in community-acquired pneumonia. ### Rationale **Blood cultures** should be obtained before antibiotic initiation in all hospitalized CAP patients: - Positive in 5–15% of CAP cases - Identifies bacteremia and guides therapy escalation - Essential for severity assessment and prognosis **Sputum Gram stain and culture:** - Provides direct visualization of organism morphology (diplococci, gram-negative rods, etc.) - Culture identifies the causative organism and allows susceptibility testing - Guides de-escalation from empiric broad-spectrum therapy to targeted antibiotics - Cost-effective and widely available ### Why This Patient Needs These Tests This patient has: - Hypoxemia (SpO₂ 88%) - Tachypnea (RR 28) - Underlying COPD (risk factor for resistant organisms) - Productive sputum (adequate specimen for culture) These features indicate moderate-to-severe CAP requiring hospitalization and microbiological confirmation before antibiotics. **High-Yield:** Sputum culture is valid only if the specimen contains ≥25 WBC/lpf and <10 epithelial cells/lpf (good quality). Blood cultures × 2 sets before antibiotics are standard of care in hospitalized pneumonia. **Clinical Pearl:** In CAP, empiric antibiotics are started immediately after cultures are obtained; results guide de-escalation within 48–72 hours, reducing antibiotic resistance and toxicity. ### Comparison with Other Investigations | Investigation | Role in CAP | Timing | |---|---|---| | Blood + sputum culture | Microbiological diagnosis, targeted therapy | Before antibiotics | | Procalcitonin/CRP | Inflammatory markers, prognosis only | Not diagnostic | | CT chest | Reserved for complications, atypical presentations | After initial assessment | | Bronchoscopy | Immunocompromised, no sputum, HAP/VAP | Not routine in CAP | [cite:Harrison 21e Ch 297]